{"id":"W2983333809","doi":"10.1182/blood-2019-126670","title":"A Phase 2 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody (Ab), in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; CD20; Mantle cell lymphoma; Rituximab; Lymphoma; Tolerability; B cell; Internal medicine; Oncology; Immunology; Gastroenterology; Antibody; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001264823,0.001627412,0.001663875,0.0004180707,0.0003227062,0.0005946395,0.0009426174,0.001129279,0.003585001],"category_scores_gemma":[0.000513527,0.0005566399,0.0009789038,0.0002576652,0.0007160027,0.0006714538,0.0003550752,0.00239796,0.0009791781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008496277,"about_ca_system_score_gemma":0.001888353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001697666,"about_ca_topic_score_gemma":0.004388251,"domain_scores_codex":[0.9997285,0.0001090751,0.00001038521,0.00006273072,0.00002894674,0.00006029855],"domain_scores_gemma":[0.9996363,0.00004866766,0.0000451761,0.00003252494,0.0000310978,0.0002061995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5357176,0.199274,0.008042418,0.001484156,0.001491939,0.0008757926,0.0005212239,0.004418005,0.09664381,0.0005118679,0.01123686,0.1397823],"study_design_scores_gemma":[0.5198948,0.4594433,0.008436512,0.00002501033,0.000386336,0.0004855493,0.00006308269,0.001698628,0.004808546,0.0002332223,0.004492357,0.00003264538],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847348,0.001861082,0.001067795,0.0005597042,0.0002223587,0.006432842,0.002259018,0.0002149966,0.002647496],"genre_scores_gemma":[0.9740264,0.002424035,0.004242992,0.001851183,0.000254648,0.005643552,0.005808743,0.00006971609,0.00567858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003585001,"threshold_uncertainty_score":0.01199305,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01519030806596407,"score_gpt":0.3004317506602245,"score_spread":0.2852414425942605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}